1 of 1
Story summary
- The panel voted 8-6 to add BPC-157, TB-500 and KPV to the bulks list, allowing compounding pharmacies to dispense them.
- The panel voted 7-5 on classifying MOTs-C.
- Health and Human Services Secretary Robert F. Kennedy Jr. said he is a “big fan” of the peptides and urged easing the Biden-era curbs.
- The FDA is not required to adopt the panel’s advice, though it often implements such recommendations.
